(Image: Screenshot of the Glooko.com website)
March 16, 2021
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
Credit: Pascale Hospital / Healthware Group
February 12, 2021
SELF-MANAGEMENT PLATFORM FOR IBD PATIENTS
Social purpose company, Ampersand Health has announced its partnership with Worcestershire Acute Hospitals NHS trust to roll out the inflammatory bowel disease (IBD) platform My IBD Care.
The initiative supports patients living with Crohn's disease and Ulcerative colitis and facilitates remote monitoring and communications between these patients and...
January 13, 2020
Type 2 diabetes management company Virta announced a whopping $93 million Series C financing round late last week. The latest round was led by Caffeinated Capital with participation from Venrock, Obvious Ventures, Creandum, Playground Global and SciFi VC.
This announcement brings the company’s total funding pot to around $166 million, coming roughly a year-and-a-half after its Series B round,...
March 11, 2019
New research set to be presented next week at the American College of Cardiology’s 68th Annual Scientific Session describes how the camera on a smartphone could be used to screen for Type 2 diabetes.
Diabetes is associated with changes to how blood flows through a person’s blood vessels, an effect that researchers from UCSF suggest could be used to detect early changes. By applying a deep...
September 6, 2018
Diabetes is a costly chronic condition, and according to the International Diabetes Federation affects at least 425 million people worldwide. As such, it’s little surprise that an increasing number of digital health companies have spotted an opportunity to help patients manage and control their disease.
In fact, that opportunity led the total revenue digital diabetes market to triple in 2017 to $...
September 5, 2018
This morning digital diabetes coaching platform Fit4D landed another $4 million in funding. The round was led by SJF Ventures, C&B Capital, Esther Dyson, and North Haven Capital, with participation from Blue Cross and Blue Shield of Nebraska and StarUP Health.
The New York City-based startup plans to use the money to continue clinical validation and development of its product.
June 19, 2018
Medical tech company Medtronic is teaming up with Nutrino, an AI powered personalized nutrition platform. Nutrino’s FoodPrint Report technology will now be integrated into Medtronic’s iPro2 myLog app, a platform that connects with a continuous glucose monitor to help give users insights about their glucose levels.
The new technology will enable doctors and clinicians to see the food that a...
January 11, 2018
A new app developed by researchers at the University of Utah may be a tool for helping people living with diabetes change their attitude towards physical activity and increase the time they plan to spend exercising. A recent study, published in the Journal of Medical Internet Research, shows that users of this app increased their plans to walk for exercise in the next week by 33.5 minutes.
October 31, 2017
Fitbit’s wearables are at the heart of recent announcements from diabetes self-management platform One Drop and the City of Santa Monica’s Office of Civic Wellbeing. The first reveals an upcoming integration that will allow users to view Fitbit device data from within the One Drop Mobile app, while the latter describes a public health initiative that will provide residents of the city with Fitbit...
May 10, 2016
Livongo, the mobile-enabled diabetes management company, has raised a strategic investment from Humana to support the company’s growth. Update: Humana invested $5 million in Livongo.
Prior to this investment, Livongo has raised at least $82.5 million to date. Just last month, the company announced a $44.5 million raise. Existing investors include Merck Global Health Innovation Fund, Cowen Private...